Lacosamide in pediatric and adult patients: Comparison of efficacy and safety

Alberto Verrotti, Giulia Loiacono, Antonella Pizzolorusso, Pasquale Parisi, Oliviero Bruni, Anna Luchetti, Nelia Zamponi, Silvia Cappanera, Salvatore Grosso, Gerhard Kluger, Christine Janello, Emilio Franzoni, Maurizio Elia, Alberto Spalice, Giangennaro Coppola, Pasquale Striano, Piero Pavone, Salvatore Savasta, Maurizio Viri, Antonino RomeoPaolo Aloisi, Giuseppe Gobbi, Alessandro Ferretti, Raffaella Cusmai, Paolo Curatolo

Research output: Contribution to journalArticlepeer-review


Purpose: This multicenter, prospective study investigates the efficacy and safety of lacosamide adjunctive therapy in pediatric and adult patients with uncontrolled epilepsy. Method: This study was carried out between September 2010 and December 2011 at 16 Italian and 1 German neurologic centers. Lacosamide was added to the baseline therapy at a starting dose of 1 mg/kg/day in patients aged

Original languageEnglish
Pages (from-to)210-216
Number of pages7
Issue number3
Publication statusPublished - Apr 2013


  • Adult
  • Antiepileptic drug
  • Children
  • Efficacy
  • Epilepsy
  • Lacosamide

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology


Dive into the research topics of 'Lacosamide in pediatric and adult patients: Comparison of efficacy and safety'. Together they form a unique fingerprint.

Cite this